A detailed history of Walleye Capital LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 1,200 shares of SWTX stock, worth $58,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,200
Previous 286,093 99.58%
Holding current value
$58,128
Previous $9.17 Million 99.53%
% of portfolio
0.0%
Previous 0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$28.61 - $42.55 $3.66 Million - $5.45 Million
-128,064 Reduced 44.76%
158,029 $5.71 Million
Q3 2024

Nov 14, 2024

BUY
$32.04 - $42.76 $9.16 Million - $12.2 Million
286,027 Added 433374.25%
286,093 $9.17 Million
Q2 2024

Aug 14, 2024

SELL
$36.06 - $47.62 $67,828 - $89,573
-1,881 Reduced 96.61%
66 $2,000
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $71,065 - $102,217
1,947 New
1,947 $95,000
Q3 2023

Nov 14, 2023

BUY
$23.12 - $31.38 $2.21 Million - $3 Million
95,694 Added 196.85%
144,307 $3.34 Million
Q2 2023

Aug 14, 2023

BUY
$23.15 - $32.71 $1.13 Million - $1.59 Million
48,613 New
48,613 $1.27 Million
Q2 2022

Aug 08, 2022

BUY
$18.36 - $60.07 $1.21 Million - $3.96 Million
65,949 New
65,949 $1.62 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $3.02B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.